<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H7A1D4639E2F349BC90D5A1EEEA02FE9D" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>117 HR 6392 IH: No Tax Breaks for Drug Ads Act</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2022-01-13</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">117th CONGRESS</congress><session display="yes">2d Session</session><legis-num display="yes">H. R. 6392</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20220113">January 13, 2022</action-date><action-desc><sponsor name-id="S001208">Ms. Slotkin</sponsor> (for herself and <cosponsor name-id="T000483">Mr. Trone</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HWM00">Committee on Ways and Means</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Internal Revenue Code of 1986 to deny the deduction for advertising and promotional expenses for prescription drugs.</official-title></form><legis-body id="H88F623985E5F45AAA8EF98A5908B0EA3" style="OLC"><section id="HDE16363A1B5B4FE6B3853DA5BEC12793" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>No Tax Breaks for Drug Ads Act</short-title></quote>.</text></section><section id="HE46575BE375A4B138AD911F24E96E729" section-type="subsequent-section"><enum>2.</enum><header>Disallowance of deduction for advertising and promotional expenses for prescription drugs</header><subsection id="H91F2D88A9FFE4ACE987FDDEA753CE29F"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">Part IX of subchapter B of chapter 1 of subtitle A of the Internal Revenue Code of 1986 (relating to items not deductible) is amended by adding at the end the following new section:</text><quoted-block display-inline="no-display-inline" id="HFD71065B300D4CA789D2BFF3C2EF3CB9" style="OLC"><section id="H87DF0FE2B00C4C979C5F2D0350E609D3"><enum>280I.</enum><header>Disallowance of deduction for direct-to-consumer advertising of prescription drugs</header><subsection id="H083C41A783C149C58B2AAF4D4C55C4B1"><enum>(a)</enum><header>In general</header><text display-inline="yes-display-inline">No deduction shall be allowed under this chapter for expenses relating to direct-to-consumer advertising of prescription drugs for any taxable year.</text></subsection><subsection id="H10908346C9844E359CD79AB9F97B1438"><enum>(b)</enum><header>Direct-to-Consumer advertising</header><text>For purposes of this section, the term <term>direct-to-consumer advertising</term> means any dissemination, by or on behalf of a sponsor of a prescription drug product (as such term is defined in section 735(3) of the Federal Food, Drug, and Cosmetic Act), of an advertisement which—</text><paragraph id="HF5A4149C754D47C4B55C3700A7AC31F2"><enum>(1)</enum><text>is in regard to such prescription drug product, and</text></paragraph><paragraph id="H5F13DE90AA1C40569D21FEF6CA306436"><enum>(2)</enum><text>primarily targeted to the general public, including through—</text><subparagraph id="HF494F75A3C9B461A96F3E0E2E12F6970"><enum>(A)</enum><text>publication in journals, magazines, other periodicals, and newspapers,</text></subparagraph><subparagraph id="HB88AFDB0F9AB4719888B074C70826804"><enum>(B)</enum><text>broadcasting through media such as radio, television, and telephone communication systems, direct mail, and billboards, and</text></subparagraph><subparagraph id="HBB6D90BDE29C4D598F4D2A29485BB1CF"><enum>(C)</enum><text>dissemination on the Internet or through digital platforms (including social media, mobile media, web applications, digital applications, mobile applications, and electronic applications).</text></subparagraph></paragraph></subsection></section><after-quoted-block>.</after-quoted-block></quoted-block></subsection><subsection id="H7ED0572C5A694C3F943FE8930B5D097E"><enum>(b)</enum><header>Conforming amendment</header><text>The table of sections for such part IX of the Internal Revenue Code of 1986 is amended by adding after the item relating to section 280H the following new item:</text><quoted-block id="H3D15F5F819554774B9FA48F017A22447" style="OLC"><toc><toc-entry idref="H87DF0FE2B00C4C979C5F2D0350E609D3" level="section">Sec. 280I. Disallowance of deduction for direct-to-consumer advertising of prescription drugs.</toc-entry></toc><after-quoted-block>.</after-quoted-block></quoted-block></subsection><subsection id="H10990635B773411AA23C8F97E3E1AB8D"><enum>(c)</enum><header>Effective date</header><text>The amendments made by this section shall apply to amounts paid or incurred after the date of the enactment of this Act, in taxable years ending after such date.</text></subsection></section></legis-body></bill> 

